- Home
- FEBO vs GLYC Comparison
FEBO vs GLYC Comparison
Compare FEBO & GLYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEBO
- GLYC
- Stock Information
- Founded
- FEBO 1993
- GLYC 2003
- Country
- FEBO Hong Kong
- GLYC United States
- Employees
- FEBO N/A
- GLYC N/A
- Industry
- FEBO
- GLYC Biotechnology: Pharmaceutical Preparations
- Sector
- FEBO
- GLYC Health Care
- Exchange
- FEBO Nasdaq
- GLYC Nasdaq
- Market Cap
- FEBO 19.4M
- GLYC 17.0M
- IPO Year
- FEBO 2023
- GLYC 2014
- Fundamental
- Price
- FEBO $1.47
- GLYC $0.26
- Analyst Decision
- FEBO
- GLYC Hold
- Analyst Count
- FEBO 0
- GLYC 2
- Target Price
- FEBO N/A
- GLYC N/A
- AVG Volume (30 Days)
- FEBO 57.8K
- GLYC 455.3K
- Earning Date
- FEBO 10-03-2024
- GLYC 11-13-2024
- Dividend Yield
- FEBO N/A
- GLYC N/A
- EPS Growth
- FEBO N/A
- GLYC N/A
- EPS
- FEBO N/A
- GLYC N/A
- Revenue
- FEBO $16,319,897.00
- GLYC $10,000.00
- Revenue This Year
- FEBO N/A
- GLYC N/A
- Revenue Next Year
- FEBO N/A
- GLYC N/A
- P/E Ratio
- FEBO N/A
- GLYC N/A
- Revenue Growth
- FEBO 9.01
- GLYC N/A
- 52 Week Low
- FEBO $1.20
- GLYC $0.14
- 52 Week High
- FEBO $17.68
- GLYC $3.52
- Technical
- Relative Strength Index (RSI)
- FEBO 41.24
- GLYC 46.98
- Support Level
- FEBO $1.54
- GLYC $0.19
- Resistance Level
- FEBO $1.72
- GLYC $0.28
- Average True Range (ATR)
- FEBO 0.21
- GLYC 0.02
- MACD
- FEBO -0.00
- GLYC 0.00
- Stochastic Oscillator
- FEBO 8.20
- GLYC 28.33
About FEBO Fenbo Holdings Limited
Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.
About GLYC GlycoMimetics Inc.
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.